Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-10

Clinical Trial Update: Microalbuminuria and Allopurinol in Type 1 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the effect of allopurinol on microalbuminuria in individuals with Type 1 diabetes and diabetic nephropathy has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: Peter Rossing | Conditions: Type 1 Diabetes, Diabetic Nephropathy | Phase 4 | Status: COMPLETED